Akt/PKB regulates hepatic metabolism by directly inhibiting PGC-1α transcription coactivator
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Type 2 diabetes mellitus, a disease with significant effects on the health and economy of Western societies, involves disturbances in both lipid and carbohydrate metabolism. In the insulin-resistant or diabetic state, the liver is unresponsive to the actions of insulin with regard to the suppression of glucose output but continues to produce large amounts of lipid, the latter mimicking the fed, insulin-replete condition. The disordered distribution of lipids contributes to the cardiovascular disease that is the greatest cause of mortality of type 2 diabetes mellitus. Yet the precise signal transduction pathways by which insulin regulates hepatic lipid synthesis and degradation remain largely unknown. Here we describe a mechanism by which insulin, through the intermediary protein kinase Akt2/protein kinase B (PKB)-beta, elicits the phosphorylation and inhibition of the transcriptional coactivator peroxisome proliferator-activated receptor-coactivator 1alpha (PGC-1alpha), a global regulator of hepatic metabolism during fasting. Phosphorylation prevents the recruitment of PGC-1alpha to the cognate promoters, impairing its ability to promote gluconeogenesis and fatty acid oxidation. These results define a mechanism by which insulin controls lipid catabolism in the liver and suggest a novel site for therapy in type 2 diabetes mellitus.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“AKT is a negative regulator of PGC-1α (Figure 3B).”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [68]
In the citing paper
“AKT phosphorylates and inhibits PGC-1α in response to insulin in liver [68] and activation of AKT causes a reduction in PGC-1α levels in heart [69].”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [68]
Citations
Cites
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Mechanisms linking obesity with cardiovascular disease
Van Gaal, L. F., Mertens, I. L., & De Block, C. E. (2006) · Nature · doi:10.1038/nature05487 · Cited by 2,814
Metabolic control through the PGC-1 family of transcription coactivators
Lin, J., Handschin, C., & Spiegelman, B. M. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.004 · Cited by 2,130
Puigserver, P., & Spiegelman, B. M. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0012 · Cited by 2,076
Cho, H., Mu, J., Kim, J. K., Thorvaldsen, J. L., Chu, Q., Crenshaw, E. B., Kaestner, K. H., Bartolomei, M. S., Shulman, G. I., & Birnbaum, M. J. (2001) · Science · doi:10.1126/science.292.5522.1728 · Cited by 1,836
Self-citationControl of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
Yoon, J. C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford, J., Kahn, C. R., Granner, D. K., et al. (2001) · Nature · doi:10.1038/35093050 · Cited by 1,821
Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction
Puigserver, P., Rhee, J., Donovan, J., Walkey, C. J., Yoon, J. C., Oriente, F., Kitamura, Y., Altomonte, J., Dong, H., Accili, D., et al. (2003) · Nature · doi:10.1038/nature01667 · Cited by 1,487
McGarry, J. D. (2002) · Diabetes · doi:10.2337/diabetes.51.1.7 · Cited by 1,435
Kohn, A. D., Summers, S. A., Birnbaum, M. J., & Roth, R. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31372 · Cited by 1,284
Self-citation
Cited by
AKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115
“In hepatocytes, Akt can also inhibit gluconeogenesis and fatty acid oxidation through direct phosphorylation of S570 on PGC-1α (Li et al., 2007), which is a coactivator that can coregulate genes with FOXO1 and other transcription factors.”
AMPK: guardian of metabolism and mitochondrial homeostasis
Herzig, S., & Shaw, R. J. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.95 · Cited by 4,061
Energy Metabolism in the Liver
Rui, L. (2014) · Comprehensive Physiology · doi:10.1002/cphy.c130024 · Cited by 1,953
“2A) (146).”
Fat and Beyond: The Diverse Biology of PPARγ
Tontonoz, P., & Spiegelman, B. M. (2008) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.77.061307.091829 · Cited by 2,085
The functions and regulation of the PTEN tumour suppressor
Song, M. S., Salmena, L., & Pandolfi, P. P. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3330 · Cited by 1,926
The PI3K/AKT Pathway in Obesity and Type 2 Diabetes
Huang, X., Liu, G., Guo, J., & Su, Z. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.27173 · Cited by 1,673
“FoxO1 and peroxisome proliferator-activated receptor-coactivator 1α (PGC1α) coordinately regulate gene expression to increase gluconeogenesis and fatty acid oxidation [32].”
BackgroundPGC-1α, SIRT1 and AMPK, an energy sensing network that controls energy expenditure
Cantó, C., & Auwerx, J. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328328d0a4 · Cited by 1,624
Insulin Receptor Signaling in Normal and Insulin-Resistant States
Boucher, J., Kleinridders, A., & Kahn, C. R. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009191 · Cited by 1,473
The nuts and bolts of AGC protein kinases
Pearce, L. R., Komander, D., & Alessi, D. R. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2822 · Cited by 1,294
“Moreover, Akt controls blood glucose levels by regulating hepatic glucose output and metabolism by phosphorylating various transcriptional regulators, including FOXO and PPARγ coactivator 1&alpha”
BackgroundAkt signalling in health and disease
Hers, I., Vincent, E. E., & Tavaré, J. M. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.05.004 · Cited by 1,239
Regulation of pgc-1α, a nodal regulator of mitochondrial biogenesis
Fernandez-Marcos, P. J., & Auwerx, J. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.001917 · Cited by 1,237
Molecular and metabolic mechanisms of insulin resistance and β-cell failure in type 2 diabetes
Muoio, D. M., & Newgard, C. B. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2327 · Cited by 1,177
Calnan, D. R., & Brunet, A. (2008) · Oncogene · doi:10.1038/onc.2008.21 · Cited by 1,170
The functions and regulation of the PTEN tumour suppressor: new modes and prospects
Lee, Y.-R., Chen, M., & Pandolfi, P. P. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0015-0 · Cited by 917
Hirschey, M. D., Shimazu, T., Jing, E., Grueter, C. A., Collins, A. M., Aouizerat, B., Stančáková, A., Goetzman, E., Lam, M. M., Schwer, B., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.07.019 · Cited by 787
“The HFD-induced suppression of Sirt3 occurs at the transcriptional level and is primarily driven by the HFD-induced suppression of PGC-1a (Crunkhorn et al., 2007; Li et al., 2007), which regulates the expression of SIRT3 (Kong et al.”
Pathophysiology of the metabolic syndrome
McCracken, E., Monaghan, M., & Sreenivasan, S. (2018) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2017.09.004 · Cited by 728
Luen Tang, B. (2016) · Molecules and Cells · doi:10.14348/molcells.2016.2318 · Cited by 740
“On the other hand, phosphorylation of PGC-1α by AKT/protein kinase B (PKB), downstream of insulin signaling in the liver, is known to decrease its stability and transcriptional activity (Li et al., 2007).”
BackgroundPGC-1 α, Inflammation, and Oxidative Stress: An Integrative View in Metabolism
Rius-Pérez, S., Torres-Cuevas, I., Millán, I., Ortega, Á. L., & Pérez, S. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/1452696 · Cited by 642
“However in the fed state, insulin stimulates PGC-1α phosphorylation by Akt, which impairs the capacity of PGC-1α to trigger fatty acid β-oxidation [33].”
BackgroundTranscriptional Control of Mitochondrial Biogenesis and Function
Hock, M. B., & Kralli, A. (2009) · Annual Review of Physiology · doi:10.1146/annurev.physiol.010908.163119 · Cited by 614
“At the posttranslational level, PGC-1α activity is regulated via phosphorylation by mitogenactivated protein kinase (MAPK) p38, AKT, AMPK, and glycogen synthase kinase-3 (GSK3) (93, 95, 99, 114, 115), (de)acetylation by GCN5 and Sirtuin 1 (SIRT1) (92, 116), arginine methylation by PRMT1 (117), ubiquitination by SCFcdc…”
BackgroundInsulin regulation of gluconeogenesis
Hatting, M., Tavares, C. D. J., Sharabi, K., Rines, A. K., & Puigserver, P. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13435 · Cited by 587
Austin, S., & St-Pierre, J. (2012) · Journal of Cell Science · doi:10.1242/jcs.113662 · Cited by 608
“Indeed, the activity of PGC1a is controlled by several post-translational modifications (Table 1), including phosphorylation (Jäger et al., 2007; Li et al., 2007; Lustig et al., 2011; Olson et al., 2008; Puigserver et al., 2001; Rodgers et al., 2010), acetylation (Lerin et al., 2006),…”
BackgroundThe role of FoxO in the regulation of metabolism
Gross, D. N., van den Heuvel, A. P. J., & Birnbaum, M. J. (2008) · Oncogene · doi:10.1038/onc.2008.25 · Cited by 540
Self-citationMetabolic adaptations through the PGC‐1α and SIRT1 pathways
Rodgers, J. T., Lerin, C., Gerhart-Hines, Z., & Puigserver, P. (2008) · FEBS Letters · doi:10.1016/j.febslet.2007.11.034 · Cited by 561
“Moreover, PGC-1a is phosphorylated by Akt/ PKB at Ser570 in the SR domain and leads to a more unstable protein with lower activity [11].”
BackgroundPGC-1α Is a Master Regulator of Mitochondrial Lifecycle and ROS Stress Response
Abu Shelbayeh, O., Arroum, T., Morris, S., & Busch, K. B. (2023) · Antioxidants · doi:10.3390/antiox12051075 · Cited by 552
“Fasting has been shown to induce SIRT1-dependent PGC-1α deacetylation in skeletal muscle and is required for the activation of mitochondrial FAO proteins under low glucose conditions [63].”
BackgroundInfluentialFasting-dependent glucose and lipid metabolic response through hepatic sirtuin 1
Rodgers, J. T., & Puigserver, P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702509104 · Cited by 466
He, L., Sabet, A., Djedjos, S., Miller, R., Sun, X., Hussain, M. A., Radovick, S., & Wondisford, F. E. (2009) · Cell · doi:10.1016/j.cell.2009.03.016 · Cited by 481
“, 2007), as well as direct inhibition of PGC-1a activity by activated AKT mediated phosphorylation (Li et al., 2007).”
PGC-1α as a Pivotal Factor in Lipid and Metabolic Regulation
Cheng, C.-F., Ku, H.-C., & Lin, H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113447 · Cited by 437
Arginine Methylation of FOXO Transcription Factors Inhibits Their Phosphorylation by Akt
Yamagata, K., Daitoku, H., Takahashi, Y., Namiki, K., Hisatake, K., Kako, K., Mukai, H., Kasuya, Y., & Fukamizu, A. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.09.013 · Cited by 435
“…this finding, we demonstrated that the C terminus of PGC-1a, which contains the major and multiple potential phosphorylation sites for Akt (Li et al., 2007), was methylated by PRMT1, and this arginine methylation completely blocked Akt-mediated phosphorylation (Figure S6B, lane 5 versus…”
BackgroundHormonal regulation of hepatic glucose production in health and disease
Lin, H. V., & Accili, D. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.06.003 · Cited by 429
“, 2001), while another shows that it promotes PGC-1a phosphorylation (Li et al., 2007).”
BackgroundSystemic elevation of PTEN induces a tumor-suppressive metabolic state
Garcia-Cao, I., Song, M. S., Hobbs, R. M., Laurent, G., Giorgi, C., de Boer, V. C. J., Anastasiou, D., Ito, K., Sasaki, A. T., Rameh, L., et al. (2012) · Cell · doi:10.1016/j.cell.2012.02.030 · Cited by 377
“Microarray analysis revealed that Super-PTEN MEFs exhibited a significant PGC-1a gene enrichment signature (Figure S4D), consistent with the fact that Akt suppresses PGC-1a function (Li et al., 2007).”
BackgroundVillena, J. A. (2015) · The FEBS Journal · doi:10.1111/febs.13175 · Cited by 405
Targeting hepatic glucose metabolism in the treatment of type 2 diabetes
Rines, A. K., Sharabi, K., Tavares, C. D. J., & Puigserver, P. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.151 · Cited by 375
Qian, L., Zhu, Y., Deng, C., Liang, Z., Chen, J., Chen, Y., Wang, X., Liu, Y., Tian, Y., & Yang, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01756-w · Cited by 338
Low-Volume Interval Training Improves Muscle Oxidative Capacity in Sedentary Adults
HOOD, M. S., LITTLE, J. P., TARNOPOLSKY, M. A., MYSLIK, F., & GIBALA, M. J. (2011) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3182199834 · Cited by 375
Impaired Mitochondrial Biogenesis in Adipose Tissue in Acquired Obesity
Heinonen, S., Buzkova, J., Muniandy, M., Kaksonen, R., Ollikainen, M., Ismail, K., Hakkarainen, A., Lundbom, J., Lundbom, N., Vuolteenaho, K., et al. (2015) · Diabetes · doi:10.2337/db14-1937 · Cited by 362
PGC-1 Coactivators in Cardiac Development and Disease
Rowe, G. C., Jiang, A., & Arany, Z. (2010) · Circulation Research · doi:10.1161/circresaha.110.223818 · Cited by 355
Pten positively regulates brown adipose function, energy expenditure, and longevity
Ortega-Molina, A., Efeyan, A., Lopez-Guadamillas, E., Muñoz-Martin, M., Gómez-López, G., Cañamero, M., Mulero, F., Pastor, J., Martinez, S., Romanos, E., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.02.001 · Cited by 356
“, 2003), and Akt phosphorylates and inhibits both Pgc1a (Li et al., 2007) and Foxo proteins (Kops et al.”
BackgroundNoland, R. C., Koves, T. R., Seiler, S. E., Lum, H., Lust, R. M., Ilkayeva, O., Stevens, R. D., Hegardt, F. G., & Muoio, D. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.032888 · Cited by 317
Regulation of glucose and lipid metabolism in health and disease
Chen, L., Chen, X.-W., Huang, X., Song, B.-L., Wang, Y., & Wang, Y. (2019) · Science China Life Sciences · doi:10.1007/s11427-019-1563-3 · Cited by 306
The Deacetylase Sirt6 Activates the Acetyltransferase GCN5 and Suppresses Hepatic Gluconeogenesis
Dominy, J. E., Lee, Y., Jedrychowski, M. P., Chim, H., Jurczak, M. J., Camporez, J. P., Ruan, H.-B., Feldman, J., Pierce, K., Mostoslavsky, R., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.09.030 · Cited by 294
“, 2008), and posttranslational modification of the mature protein (Li et al., 2007; Rodgers et al., 2005, 2010; Teyssier et al., 2005).”
BackgroundSheng, H., & Sun, H. (2011) · Natural Product Reports · doi:10.1039/c0np00059k · Cited by 289
Bo, T., Gao, L., Yao, Z., Shao, S., Wang, X., Proud, C. G., & Zhao, J. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.04.006 · Cited by 293
Palomer, X., Salvadó, L., Barroso, E., & Vázquez-Carrera, M. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.07.150 · Cited by 289
Akt2 Is Required for Hepatic Lipid Accumulation in Models of Insulin Resistance
Leavens, K. F., Easton, R. M., Shulman, G. I., Previs, S. F., & Birnbaum, M. J. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.10.004 · Cited by 281
“Nonetheless, the prevalent model of hepatic insulin signaling is that activated Akt phosphorylates and inhibits the transcription factor FoxO, peroxisome proliferator-activated receptor-coactivator-1a (PGC-1a), and others, thereby terminating expression of the rate-controlling enzymes of gluconeogenesis (Gross et al.,…”
BackgroundSelf-citationObesity-induced Insulin Resistance and Hyperglycemia: Etiologic Factors and Molecular Mechanisms
Martyn, J. A. J., Kaneki, M., Yasuhara, S., Warner, D. S., & Warner, M. A. (2008) · Anesthesiology · doi:10.1097/aln.0b013e3181799d45 · Cited by 265
Molecular Mechanisms of Glucocorticoid-Induced Insulin Resistance
Beaupere, C., Liboz, A., Fève, B., Blondeau, B., & Guillemain, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020623 · Cited by 271
AMPK: Regulation of Metabolic Dynamics in the Context of Autophagy
Tamargo-Gómez, I., & Mariño, G. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123812 · Cited by 252
Protein Kinase B (PKB/Akt), a Key Mediator of the PI3K Signaling Pathway
Fayard, E., Xue, G., Parcellier, A., Bozulic, L., & Hemmings, B. A. (2010) · Current Topics in Microbiology and Immunology · doi:10.1007/82_2010_58 · Cited by 247
The role of FOXO in the regulation of metabolism
Gross, D. N., Wan, M., & Birnbaum, M. J. (2009) · Current Diabetes Reports · doi:10.1007/s11892-009-0034-5 · Cited by 240
“Insulin inhibits PGC-1α activity directly through Akt-dependent phosphorylation or indirectly by antagonizing the glucagon signaling pathway [ 5 ].”
BackgroundSelf-citationPTEN and PI3K/AKT in Non-Small-Cell Lung Cancer
Pérez-Ramírez, C., Cañadas-Garre, M., Molina, M. Á., Faus-Dáder, M. J., & Calleja-Hernández, M. Á. (2015) · Pharmacogenomics · doi:10.2217/pgs.15.122 · Cited by 236
Insulin Resistance and Diabetes Mellitus in Alzheimer’s Disease
Burillo, J., Marqués, P., Jiménez, B., González-Blanco, C., Benito, M., & Guillén, C. (2021) · Cells · doi:10.3390/cells10051236 · Cited by 225
Cyclin D1-Cdk4 controls glucose metabolism independently of cell cycle progression
Lee, Y., Dominy, J. E., Choi, Y. J., Jurczak, M., Tolliday, N., Camporez, J. P., Chim, H., Lim, J.-H., Ruan, H.-B., Yang, X., et al. (2014) · Nature · doi:10.1038/nature13267 · Cited by 234
Metabolic Reprogramming Is Required for Myofibroblast Contractility and Differentiation
Bernard, K., Logsdon, N. J., Ravi, S., Xie, N., Persons, B. P., Rangarajan, S., Zmijewski, J. W., Mitra, K., Liu, G., Darley-Usmar, V. M., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.646984 · Cited by 224
“PGC-1α contains multiple phosphorylation sites that are targets of different signaling pathways, thus conferring to PGC-1α its role as a signaling integrator (25,26).”
BackgroundMetabolic aspects in NAFLD, NASH and hepatocellular carcinoma: the role of PGC1 coactivators
Piccinin, E., Villani, G., & Moschetta, A. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0089-3 · Cited by 231
Mutual Dependence of Foxo3a and PGC-1α in the Induction of Oxidative Stress Genes
Olmos, Y., Valle, I., Borniquel, S., Tierrez, A., Soria, E., Lamas, S., & Monsalve, M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807397200 · Cited by 224
Adenanthin targets peroxiredoxin I and II to induce differentiation of leukemic cells
Liu, C.-X., Yin, Q.-Q., Zhou, H.-C., Wu, Y.-L., Pu, J.-X., Xia, L., Liu, W., Huang, X., Jiang, T., Wu, M.-X., et al. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.935 · Cited by 221
Self-citationPGC-1 coactivators in the control of energy metabolism
Liu, C., & Lin, J. D. (2011) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmr007 · Cited by 210
Selective Chemical Inhibition of PGC-1α Gluconeogenic Activity Ameliorates Type 2 Diabetes
Sharabi, K., Lin, H., Tavares, C. D. J., Dominy, J. E., Camporez, J. P., Perry, R. J., Schilling, R., Rines, A. K., Lee, J., Hickey, M., et al. (2017) · Cell · doi:10.1016/j.cell.2017.03.001 · Cited by 210
Miller, V. J., Villamena, F. A., & Volek, J. S. (2018) · Journal of Nutrition and Metabolism · doi:10.1155/2018/5157645 · Cited by 199
“In contrast, insulin decreases PGC-1α activity through phosphorylation by PKB [285].”
BackgroundDeposition of 5-Methylcytosine on Enhancer RNAs Enables the Coactivator Function of PGC-1α
Aguilo, F., Li, S., Balasubramaniyan, N., Sancho, A., Benko, S., Zhang, F., Vashisht, A., Rengasamy, M., Andino, B., Chen, C.-H., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2015.12.043 · Cited by 201
“PGC-1a is acetylated by the histone acetyltransferase GCN5 of the Spt-Ada-Gcn5-acetyltransferase (SAGA) complex (Kelly et al., 2009; Lerin et al., 2006), deacetylated by SIRT1 (Nemoto et al., 2005; Rodgers et al., 2005), serine phosphorylated by AKT/PKB (Li et al., 2007), AMPK, p38 MAPK, and GSK3b (Fernandez-Marcos an…”
BackgroundThe hitchhiker’s guide to PGC-1α isoform structure and biological functions
Martínez-Redondo, V., Pettersson, A. T., & Ruas, J. L. (2015) · Diabetologia · doi:10.1007/s00125-015-3671-z · Cited by 202
“Kinases that target PGC-1α1 include p38 mitogen-activated protein kinase [20], protein kinase B [21], S6 kinase [22], AMPK [23] and glycogen synthase kinase 3β (GSK3β) [24].”
BackgroundJitrapakdee, S. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.10.001 · Cited by 195
Dominy, J. E., Lee, Y., Gerhart-Hines, Z., & Puigserver, P. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.11.023 · Cited by 192
“PGC-1α undergoes other forms of post-translational modifications such as phosphorylation [14,65,66], ubiquitination [67], O-linked β-Nacetylglucosamination [68], and methylation [69].”
BackgroundThe Role of PGC1α in Cancer Metabolism and its Therapeutic Implications
Tan, Z., Luo, X., Xiao, L., Tang, M., Bode, A. M., Dong, Z., & Cao, Y. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0621 · Cited by 189
Jeninga, E. H., Schoonjans, K., & Auwerx, J. (2010) · Oncogene · doi:10.1038/onc.2010.206 · Cited by 193
“…regulation of its expression level, PGC1a activity is controlled by a variety of posttranslational modifications, including phosphorylation (Puigserver et al., 2003; Jager et al., 2007; Li et al., 2007), ubiquitination (Olson et al., 2008) and acetylation (Rodgers et al., 2005; Lerin et al., 2006).”
BackgroundPPAR control: it's SIRTainly as easy as PGC
Sugden, M. C., Caton, P. W., & Holness, M. J. (2010) · Journal of Endocrinology · doi:10.1677/joe-09-0359 · Cited by 192
Serine-arginine protein kinases: a small protein kinase family with a large cellular presence
Giannakouros, T., Nikolakaki, E., Mylonis, I., & Georgatsou, E. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2010.07987.x · Cited by 188
Álvarez-Guardia, D., Palomer, X., Coll, T., Davidson, M. M., Chan, T. O., Feldman, A. M., Laguna, J. C., & Vázquez-Carrera, M. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq080 · Cited by 187
Olson, B. L., Hock, M. B., Ekholm-Reed, S., Wohlschlegel, J. A., Dev, K. K., Kralli, A., & Reed, S. I. (2008) · Genes & Development · doi:10.1101/gad.1624208 · Cited by 185
“It has been recently reported that in hepatocytes, activation of AKT/ PKB by insulin directly inhibits PGC-1 by phosphorylation on Ser570 (Li et al. 2007).”
BackgroundIncreased Expression and Activity of the Transcription Factor FOXO1 in Nonalcoholic Steatohepatitis
Valenti, L., Rametta, R., Dongiovanni, P., Maggioni, M., Ludovica Fracanzani, A., Zappa, M., Lattuada, E., Roviaro, G., & Fargion, S. (2008) · Diabetes · doi:10.2337/db07-0714 · Cited by 187
Chen, L., Qin, Y., Liu, B., Gao, M., Li, A., Li, X., & Gong, G. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.871357 · Cited by 171
Self-citationRole of PI3K/Akt signaling in memory CD8 T cell differentiation
Kim, E. H., & Suresh, M. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00020 · Cited by 182
“…activities of mTORC1 and GSK3, Akt also phosphorylates and inactivates forkhead box O (FOXO) transcription factors in the nucleus thereby dampening the expression of FOXO target genes involved in proliferation, apoptosis, motility, and metabolism (Li et al., 2007; Hedrick et al., 2012; Figure 1).”
BackgroundSIRT3 regulates mitochondrial protein acetylation and intermediary metabolism
Hirschey, M. D., Shimazu, T., Huang, J. Y., Schwer, B., & Verdin, E. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.010850 · Cited by 180
“The suppression of SIRT3 occurs at the transcriptional level and is primarily driven by the HFD-induced suppression of PGC-1a (Crunkhorn et al. 2007; Li et al. 2007), a major regulator of SIRT3 expression (Kong et al. 2010; JY Huang and E Verdin, unpubl.).”
BackgroundWang, C.-Y., Kim, H.-H., Hiroi, Y., Sawada, N., Salomone, S., Benjamin, L. E., Walsh, K., Moskowitz, M. A., & Liao, J. K. (2009) · Science Signaling · doi:10.1126/scisignal.2000143 · Cited by 177
“In addition, Akt has been shown to inhibit the transcriptional coactivator peroxisome proliferator–activated receptor coactivator 1a (PGC-1a) (48).”
BackgroundDietary Iron Overload Induces Visceral Adipose Tissue Insulin Resistance
Dongiovanni, P., Ruscica, M., Rametta, R., Recalcati, S., Steffani, L., Gatti, S., Girelli, D., Cairo, G., Magni, P., Fargion, S., et al. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.02.019 · Cited by 158
Cervelli, V., Scioli, M. G., Gentile, P., Doldo, E., Bonanno, E., Spagnoli, L. G., & Orlandi, A. (2012) · Stem Cells Translational Medicine · doi:10.5966/sctm.2011-0052 · Cited by 170
Insulin signaling to hepatic lipid metabolism in health and disease
Leavens, K. F., & Birnbaum, M. J. (2011) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2011.562481 · Cited by 164
“Akt directly phosphorylates PGC-1α, at serine-570, impairing its ability to activate genes involved in fatty acid oxidation, in particular, medium-chain acetyl-CoA dehydrogenase (Li et al., 2007).”
BackgroundInfluentialSelf-citationLipid oversupply, selective insulin resistance, and lipotoxicity: Molecular mechanisms
Chavez, J. A., & Summers, S. A. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.09.015 · Cited by 169
Li, L., Pan, R., Li, R., Niemann, B., Aurich, A.-C., Chen, Y., & Rohrbach, S. (2011) · Diabetes · doi:10.2337/db10-0331 · Cited by 158
“AMP-activated protein kinase (12), p38 MAPK (9,10), and protein kinase B (Akt) (14) phosphorylate PGC-1 , modifying its stability and activity (rev.”
BackgroundWang, X., Huang, N., Yang, M., Wei, D., Tai, H., Han, X., Gong, H., Zhou, J., Qin, J., Wei, X., et al. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.122 · Cited by 164
Jin, X., Moskophidis, D., & Mivechi, N. F. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.03.025 · Cited by 163
“In liver, insulin, through activation of IR and AKT, suppresses hepatic gluconeogenesis by negatively regulating Foxo1, PCG1a, and CRTC2 (Dentin et al., 2007; Gross et al., 2008; Li et al., 2007).”
PGC-1α in aging and anti-aging interventions
Anderson, R., & Prolla, T. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.04.005 · Cited by 162
“AKT phosphorylates and inhibits PGC-1α in response to insulin in liver [68] and activation of AKT causes a reduction in PGC-1α levels in heart [69].”
Yuan, M., Pino, E., Wu, L., Kacergis, M., & Soukas, A. A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.386854 · Cited by 154
Rapid exercise-induced changes in PGC-1α mRNA and protein in human skeletal muscle
Mathai, A. S., Bonen, A., Benton, C. R., Robinson, D. L., & Graham, T. E. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00847.2007 · Cited by 158
MicroRNA 33 Regulates Glucose Metabolism
Ramírez, C. M., Goedeke, L., Rotllan, N., Yoon, J.-H., Cirera-Salinas, D., Mattison, J. A., Suárez, Y., de Cabo, R., Gorospe, M., & Fernández-Hernando, C. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00016-13 · Cited by 154
Alternative mRNA Splicing Produces a Novel Biologically Active Short Isoform of PGC-1α
Zhang, Y., Huypens, P., Adamson, A. W., Chang, J. S., Henagan, T. M., Boudreau, A., Lenard, N. R., Burk, D., Klein, J., Perwitz, N., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.037556 · Cited by 148
Turn up the power - pharmacological activation of mitochondrial biogenesis in mouse models
Komen, J. C., & Thorburn, D. R. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12413 · Cited by 149
“Additionally, inhibition of PGC-1α also occurs by phosphorylation of a specific site by Akt/PKB in response to insulin signalling (Li et al., 2007).”
BackgroundEstall, J. L., Kahn, M., Cooper, M. P., Fisher, F. M., Wu, M. K., Laznik, D., Qu, L., Cohen, D. E., Shulman, G. I., & Spiegelman, B. M. (2009) · Diabetes · doi:10.2337/db08-1571 · Cited by 148
“Glucagon increases hepatic PGC-1 (cid:2) expression during a fast, whereas insulin potently inhibits PGC-1 (cid:2) expression and activity (6–10).”
Protein kinase B: signalling roles and therapeutic targeting
Sale, E. M., & Sale, G. J. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7274-9 · Cited by 174
The Early Origins of Obesity and Insulin Resistance: Timing, Programming and Mechanisms
Nicholas, L. M., Morrison, J. L., Rattanatray, L., Zhang, S., Ozanne, S. E., & McMillen, I. C. (2016) · International Journal of Obesity · doi:10.1038/ijo.2015.178 · Cited by 146
Connaughton, S., Chowdhury, F., Attia, R. R., Song, S., Zhang, Y., Elam, M. B., Cook, G. A., & Park, E. A. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.08.011 · Cited by 144
Alkhalidy, H., Moore, W., Wang, A., Luo, J., McMillan, R. P., Wang, Y., Wei, Z. C., Hulver, M. W., & Liu, D. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.04.014 · Cited by 157
Mitochondrial metabolism supports resistance to IDH mutant inhibitors in acute myeloid leukemia
Stuani, L., Sabatier, M., Wang, F., Poupin, N., Bosc, C., Saland, E., Castelli, F. A., Gales, L., Montersino, C., Boët, E., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20200924 · Cited by 155
Kim, D.-K., Ryu, D., Koh, M., Lee, M.-W., Lim, D., Kim, M.-J., Kim, Y.-H., Cho, W.-J., Lee, C.-H., Park, S. B., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.315168 · Cited by 134
Honka, M.-J., Latva-Rasku, A., Bucci, M., Virtanen, K. A., Hannukainen, J. C., Kalliokoski, K. K., & Nuutila, P. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-0882 · Cited by 140
Wan, M., Leavens, K. F., Saleh, D., Easton, R. M., Guertin, D. A., Peterson, T. R., Kaestner, K. H., Sabatini, D. M., & Birnbaum, M. J. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.09.001 · Cited by 138
“…implicating FoxO1 as an intermediate in the pathway by which insulin through Akt suppresses hepatic gluconeogenic gene expression and glucose output (Haeusler et al., 2010b; Li et al., 2007; Liu et al., 2008; Matsumoto et al., 2007; Nakae et al., 2001; Puigserver et al., 2003; Qu et al., 2006).”
BackgroundSelf-citationVEGF stimulation of mitochondrial biogenesis: requirement of AKT3 kinase
Wright, G. L., Maroulakou, I. G., Eldridge, J., Liby, T. L., Sridharan, V., Tsichlis, P. N., & Muise‐Helmericks, R. C. (2008) · The FASEB Journal · doi:10.1096/fj.08-106468 · Cited by 130
“The first involves a direct phosphorylation of FoxO1, resulting in its cytoplasmic localization and blockade of its interaction with PGC-1-dependent target genes ( 42 ).”
BackgroundGCN5-mediated Transcriptional Control of the Metabolic Coactivator PGC-1β through Lysine Acetylation
Kelly, T. J., Lerin, C., Haas, W., Gygi, S. P., & Puigserver, P. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.015164 · Cited by 130
Tohme, S. T., Yazdani, H. O., Liu, Y., Loughran, P., van der Windt, D. J., Huang, H., Simmons, R. L., Shiva, S., Tai, S., & Tsung, A. (2017) · Hepatology · doi:10.1002/hep.29184 · Cited by 138
“PGC-1a activity, and consequently the upregulation of mitochondrial biogenesis, is determined not only by PGC-1a expression levels but also by a number of posttranslational modifications, such as phosphorylation.((27-29)) Figure 6B shows that hypoxia is accompanied by increased phosphorylated PGC-1a (pPGC-1a) in Hep1-…”
BackgroundBayascas, J. R., Wullschleger, S., Sakamoto, K., García-Martínez, J. M., Clacher, C., Komander, D., van Aalten, D. M. F., Boini, K. M., Lang, F., Lipina, C., et al. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.02032-07 · Cited by 131
Metadata
- Authors
- Li, X., Monks, B., Ge, Q., & Birnbaum, M. J.
- Affiliations
- Howard Hughes Medical Institute (US)
- Cell Signaling Technology (United States) (US)
- Corresponding author
- Birnbaum, Morris J.
- Venue
- Nature
- Published
- 2007-06
- Volume
- 447
- Issue
- 7147
- Pages
- 1012-1016
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1982810858
- Cited by
- 487
- References
- 29
- Citations by year
- 2026: 6 · 2025: 19 · 2024: 25 · 2023: 19 · 2022: 16 · 2021: 26 · 2020: 33 · 2019: 21 · 2018: 27 · 2017: 24 · 2016: 15 · 2015: 24 · 2014: 26 · 2013: 24 · 2012: 32
- FWCI
- 13.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- PGC-1α, insulin signaling, hepatic metabolism, type 2 diabetes, insulin resistance, gluconeogenesis, fatty acid oxidation, cardiovascular disease
- MeSH terms
- Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha, Animals, Chromatin, Diabetes Mellitus, Type 2, Gene Expression Regulation, Glucose, Liver, Phosphorylation, Phosphoserine, Transcription Factors, Trans-Activators, Down-Regulation, Cell Line, Tumor, Proto-Oncogene Proteins c-akt, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.